|
1
|
Davis RL, Weintraub H and Lassar AB:
Expression of a single transfected cDNA converts fibroblasts to
myoblasts. Cell. 51:987–1000. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Takahashi K and Yamanaka S: Induction of
pluripotent stem cells from mouse embryonic and adult fibroblast
cultures by defined factors. Cell. 126:663–676. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yamanaka S: Pluripotency and nuclear
reprogramming. Philos Trans R Soc Lond B Biol Sci. 363:2079–2087.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gu G, Dubauskaite J and Melton DA: Direct
evidence for the pancreatic lineage: NGN3+ cells are islet
progenitors and are distinct from duct progenitors. Development.
129:2447–2457. 2002.PubMed/NCBI
|
|
5
|
Zhou Q, Brown J, Kanarek A, Rajagopal J
and Melton DA: In vivo reprogramming of adult pancreatic exocrine
cells to beta-cells. Nature. 455:627–632. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Puligilla C, Dabdoub A, Brenowitz SD and
Kelley MW: Sox2 induces neuronal formation in the developing
mammalian cochlea. J Neurosci. 30:714–722. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu X, Li F, Stubblefield EA, Blanchard B,
Richards TL, Larson GA, He Y, Huang Q, Tan AC, Zhang D, et al:
Direct reprogramming of human fibroblasts into dopaminergic
neuron-like cells. Cell Res. 22:321–332. 2012. View Article : Google Scholar :
|
|
8
|
Vierbuchen T, Ostermeier A, Pang ZP,
Kokubu Y, Südhof TC and Wernig M: Direct conversion of firoblasts
to functional neurons by defied factors. Nature. 463:1035–1041.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pang ZP, Yang N, Vierbuchen T, Ostermeier
A, Fuentes DR, Yang TQ, Citri A, Sebastiano V, Marro S, Südhof TC
and Wernig M: Induction of human neuronal cells by defined
transcription factors. Nature. 476:220–223. 2011.PubMed/NCBI
|
|
10
|
Caiazzo M, Dell'Anno MT, Dvoretskova E,
Lazarevic D, Taverna S, Leo D, Sotnikova TD, Menegon A, Roncaglia
P, Colciago G, et al: Direct generation of functional dopaminergic
neurons from mouse and human firoblasts. Nature. 476:224–227. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pfisterer U, Kirkeby A, Torper O, Wood J,
Nelander J, Dufour A, Björklund A, Lindvall O, Jakobsson J and
Parmar M: Direct conversion of human firoblasts to dopaminergic
neurons. Proc Natl Acad Sci USA. 108:10343–10348. 2011. View Article : Google Scholar
|
|
12
|
Son EY, Ichida JK, Wainger BJ, Toma JS,
Rafuse VF, Woolf CJ and Eggan K: Conversion of mouse and human
fibroblasts into functional spinal motor neurons. Cell Stem Cell.
9:205–218. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Castro DS, Martynoga B, Parras C, Ramesh
V, Pacary E, Johnston C, Drechsel D, Lebel-Potter M, Garcia LG,
Hunt C, et al: A novel function of the proneural factor Ascl1 in
progenitor proliferation identified by genome-wide characterization
of its targets. Genes Dev. 25:930–945. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Thomas JL, Baker K, Han J, Calvo C, Nurmi
H, Eichmann AC and Alitalo K: Interactions between VEGFR and notch
signaling pathways in endothelial and neural cells. Cell Mol Life
Sci. 70:1779–1792. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hsieh FY, Ma TL, Shih HY, Lin SJ, Huang
CW, Wang HY and Cheng YC: Dner inhibits neural progenitor
proliferation and induces neuronal and glial differentiation in
zebrafish. Dev Biol. 375:1–12. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zabierowski SE, Baubet V, Himes B, Li L,
Fukunaga-Kalabis M, Patel S, McDaid R, Guerra M, Gimotty P, Dahmane
N and Herlyn M: Direct reprogramming of melanocytes to neural crest
stem-like cells by one defined factor. Stem Cells. 29:1752–1762.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kutner RH, Zhang XY and Reiser J:
Production, concentration and titration of pseudotyped HIV-1-based
lentiviral vectors. Nat Protoc. 4:495–505. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Benraiss A, Chmielnicki E, Lerner K, Roh D
and Goldman SA: Adenoviral brain-derived neurotrophic factor
induces both neostriatal and olfactory neuronal recruitment from
endogenous progenitor cells in the adult forebrain. J Neurosci.
21:6718–6731. 2011.
|
|
19
|
Pencea V, Bingaman KD, Wiegand SJ and
Luskin MB: Infusion of brain-derived neurotrophic factor into the
lateral ventricle of the adult rat leads to new neurons in the
parenchyma of the striatum, septum, thalamus and hypothalamus. J
Neurosci. 21:6706–6717. 2011.
|
|
20
|
Xia Y, Wang CZ, Liu J, Anastasio NC and
Johnson KM: Brain-derived neurotrophic factor prevents
phencyclidine-induced apoptosis in developing brain by parallel
activation of both the ERK and PI-3K/Akt pathways.
Neuropharmacology. 58:330–336. 2010. View Article : Google Scholar :
|
|
21
|
Mullen LM, Pak KK, Chavez E, Kondo K,
Brand Y and Ryan AF: Ras/p38 and PI3K/Akt but not Mek/Erk signaling
mediate BDNF-induced neurite formation on neonatal cochlear spiral
ganglion explants. Brain Res. 1430:25–34. 2012. View Article : Google Scholar
|
|
22
|
Südhof TC: The structure of the human
synapsin I gene and protein. J Biol Chem. 265:7849–7852.
1990.PubMed/NCBI
|
|
23
|
Huttner WB, Schiebler W, Greengard P and
De Camilli P: Synapsin I (protein I), a nerve terminal-specific
phosphoprotein. III. Its association with synaptic vesicles studied
in a highly purified synaptic vesicle preparation. J Cell Biol.
96:1374–1388. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Osaki M, Oshimura M and Ito H: PI3K-Akt
pathway: Its functions and alterations in human cancer. Apoptosis.
9:667–676. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang S and Houghton PJ: Targeting mTOR
signaling for cancer therapy. Curr Opin Pharmacol. 3:371–377. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qian Y, Corum L, Meng Q, Blenis J, Zheng
JZ, Shi X, Flynn DC and Jiang BH: PI3K induced actin filament
remodeling through Akt and p70S6K1: Implication of essential role
in cell migration. Am J Physiol Cell Physiol. 286:C153–C163. 2004.
View Article : Google Scholar
|
|
27
|
Wapinski OL, Vierbuchen T, Qu K, Lee QY,
Chanda S, Fuentes DR, Giresi PG, Ng YH, Marro S, Neff NF, et al:
Hierarchical mechanisms for direct reprogramming of fibroblasts to
neurons. Cell. 155:621–635. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bertrand N, Castro DS and Guillemot F:
Proneural genes and the specification of neural cell types. Nat Rev
Neurosci. 3:517–530. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ross SE, Greenberg ME and Stiles CD: Basic
helix-loop-helix factors in cortical development. Neuron. 39:13–25.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Banito A and Gil J: Induced pluripotent
stem cells and senescence: Learning the biology to improve the
technology. EMBO Rep. 11:353–359. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Salama I, Malone PS, Mihaimeed F and Jones
JL: A review of the S100 proteins in cancer. Eur J Surg Oncol.
34:357–364. 2008. View Article : Google Scholar
|
|
32
|
Andrés R, Mayordomo JI, Zaballos P, Rodino
J, Isla D, Escudero P, Elosegui L, Filipovich E, Saenz A, Polo E
and Tres A: Prognostic value of serum S-100B in malignant melanoma.
Tumori. 90:607–610. 2004.
|
|
33
|
Blesch A, Bosserhoff AK, Apfel R, Behl C,
Hessdoerfer B, Schmitt A, Jachimczak P, Lottspeich F, Buettner R
and Bogdahn U: Cloning of a novel malignant melanoma-derived growth
regulatory protein, MIA. Cancer Res. 54:5695–5701. 1994.PubMed/NCBI
|
|
34
|
Kazakova MH and Sarafian VS: YKL-40-a
novel biomarker in clinical practice? Folia Med (Plovdiv). 51:5–14.
2009.
|
|
35
|
Yilmazer A, de Lázaro I and Taheri H:
Reprogramming cancer cells: A novel approach for cancer therapy or
a tool for disease-modeling? Cancer Lett. 369:1–8. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cheng H, Liu C, Cai X, Lu Y, Xu Y and Yu
X: iPSCs derived from malignant tumor cells: Potential application
for cancer research. Curr Stem Cell Res Ther. 11:1–7. 2016.
View Article : Google Scholar
|
|
37
|
Su Z, Zang T, Liu ML, Wang LL, Niu W and
Zhang CL: Reprogramming the fate of human glioma cells to impede
brain tumor development. Cell Death Dis. 5:e14632014. View Article : Google Scholar : PubMed/NCBI
|
